Ashley Tabi

Ashley Tabi practices at Citymd Urgent Care in Bronx, New York.

Ashley Tabi's NPI, 1285013326, was assigned on May 21, 2015. Ashley Tabi holds New York license 296260.

Ashley Tabi's primary practice is Citymd Urgent Care, at 2146 A Bartow Ave, Bronx, NY 10475 in Bronx County. The practice phone is (516) 783-4600.

Ashley Tabi's primary practice is Citymd Urgent Care in Bronx, New York. The medical group on file is CityMD. Dmand AI also links Ashley Tabi to 1 more physician office, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Ashley Tabi practices. Vendor and product names are available with a free account.

Family medicine is Ashley Tabi's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Ashley Tabi is licensed in New York.

CMS data shows 257 Medicare services from Ashley Tabi across 7 procedure codes in 2024, for 179 Medicare patients. Medicare paid $16,241 for them. Every service was in an office.

CMS counts 179 Medicare patients who saw Ashley Tabi in 2024. The largest group is 65 to 74, with 88 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 17% are also on Medicaid. Their average risk score is 0.84, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Ashley Tabi's median patient age at 33, with 69% women.

In 2024, Ashley Tabi wrote 247 Medicare Part D claims for 190 patients. 91% of them were for generic drugs. CMS names the drug for 131 of them, across 6 drugs with 11 or more claims each, at $730 in total drug cost. In 2023, CMS named 129 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Ashley Tabi for performance year 2024, reported as part of a group. Ashley Tabi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 3 general payments to Ashley Tabi from 3 drug and device companies from 2017 to 2022. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $24.